Cowen Healthcare Investments raises USD493m for third fund
Cowen Healthcare Investments (CHI) has successfully completed fundraising for Cowen Healthcare Investments III LP (CHI III)with USD493 million, USD93 million above the Fund’s original target.
CHI received commitments from existing and new investors, including institutional investors, family offices, and high net worth individuals.
Led by Kevin Raidy, Tim Anderson, and Robert Sine, CHI was founded in 2012 to support innovation in the healthcare sector, with a particular focus on biopharma, diagnostics and digital health. CHI focuses its investment activity on established companies with outstanding management teams and disruptive approaches to disease that address significant unfulfilled medical needs. Since 2012 the team has invested in 38 private healthcare companies. Pedro Alvarez-Urena, PhD and Eric Pham, PhD have joined the team over the past two years.
Kevin Raidy, Managing Partner, CHI, says: “Investing in premier life sciences companies could not be more critical than it is today. We are extremely optimistic about the prospects of this industry to address urgent, unmet medical needs, and in doing so to transform the lives of patients and their families. We feel privileged to be able to partner with exceptional management teams and like-minded investors to help build the next generation of world-class, innovative healthcare companies.”
Elizabeth Flisser Rosman, Cowen Managing Director and Head of Investment Management, adds: “As part of Cowen’s DNA, Cowen Healthcare Investments demonstrates our organisation’s ability to identify, develop, and deliver differentiated investment strategies. Using Cowen’s powerful platform, we look forward to developing additional investment products that meet our clients’ needs and create long-term value for all of Cowen’s stakeholders.”